BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Press Releases

  Kyowa Kirin Announces Top-line Data from Rocatinlimab Phase 3 ROCKET HORIZON Trial for Adults with Moderate to Severe Atopic Dermatitis

  September 26, 2024

   · 

  8 min read
• Press Releases

  UCB Presents New 4-year Data for BIMZELX® (bimekizumab-bkzx) in Moderate-to-Severe Plaque Psoriasis at EADV 2024

  September 26, 2024

   · 

  15 min read
• Press Releases

  New data show Lilly’s EBGLYSS™ (lebrikizumab-lbkz) provided sustained disease control for up to three years in more than 80% of adults and adolescents with moderate-to-severe atopic dermatitis

  September 26, 2024

   · 

  12 min read
• Press Releases

  Ocular Therapeutix™ to Present at the UBS Virtual Opthalmology Day 2024

  September 26, 2024

   · 

  1 min read
• Press Releases

  Oruka Therapeutics Announces Preclinical Data for ORKA-001 at the European Academy of Dermatology and Venereology Congress

  September 26, 2024

   · 

  5 min read
• Press Releases

  Apellis Pharmaceuticals to Host a Fireside Chat at the UBS Virtual Ophthalmology Day

  September 26, 2024

   · 

  1 min read
• Press Releases

  Kymera Therapeutics Presents Preclinical Data for KT-621, a Potent, Selective, First-In-Class, Oral STAT6 Degrader at the EADV Congress

  September 26, 2024

   · 

  8 min read
• Press Releases

  New Analysis Demonstrates the Efficacy of RINVOQ® (upadacitinib) in Atopic Dermatitis with Varying Degrees of Severity in Head and Neck Involvement

  September 26, 2024

   · 

  23 min read
• Press Releases

  Multiple Late-Breaking Data Presentations from Incyte’s Dermatology Portfolio will be Featured at the European Academy of Dermatology and Venereology (EADV) 2024 Congress

  September 26, 2024

   · 

  6 min read
• Press Releases

  InflaRx Presents Post Hoc Analysis of SHINE Trial of Vilobelimab in Hidradenitis Suppurativa at the 2024 European Academy of Dermatology and Venereology Congress

  September 26, 2024

   · 

  6 min read